Family, the distribution ratio has not been determined as of yet but the share distribution is for share holders on record as of July 31st and it will take place, so far, end of September - GLTU
HCIT
HCIT
Recent LCTX News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2026 08:20:06 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2026 08:15:01 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2026 08:10:18 PM
- Lineage Announces Formation of Scientific Advisory Board • Business Wire • 04/13/2026 12:00:00 PM
- Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease • Business Wire • 03/24/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:05:10 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/11/2026 01:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 01:00:26 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/11/2026 01:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2026 12:51:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2026 12:50:33 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 09:10:24 PM
- Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • Business Wire • 03/05/2026 09:01:00 PM
- Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 • Business Wire • 02/26/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2026 12:30:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2026 12:30:03 AM
- Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience • Business Wire • 01/06/2026 01:00:00 PM
- Lineage Cell Therapeutics Issues Letter to Stockholders • Business Wire • 01/05/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2025 02:55:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2025 02:55:03 AM
- Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy • PR Newswire (Canada) • 12/16/2025 04:53:00 PM
- Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy • PR Newswire (US) • 12/16/2025 04:53:00 PM
